通过向ASC来抑制炎症酶激活,Madecassoside可以缓解Clostridioides difficile感染
Wei Chen1, Yichen Zhao2, Liang Hu3
1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
International immunopharmacology
|August 30, 2025
概括
通过减少炎症,madecassoside (MA) 有效地缓解了小鼠的困难菌感染 (CDI) 症状. 通过与ASC结合,MA抑制了炎症酶路径,为CDI提供了新的治疗策略.
科学领域:
- 药理学
- 免疫学
- 微生物学
背景情况:
- 困难菌感染 (CDI) 是与医疗相关的腹的重要原因.
- 这种由毒素引起的炎症是CDI的关键特征.
- 麦德卡索 (MA) 来自亚洲,具有抗炎性质,但其在CDI中的作用尚未被探索.
研究的目的:
- 在Clostridioides difficile感染 (CDI) 的小鼠模型中研究Madecassoside (MA) 的治疗作用和潜在机制.
主要方法:
- 建立了一个CDI小鼠模型来评估MA的体内疗效.
- 使用原始骨髓衍生的巨细胞 (BMDM) 来创建由C. difficile刺激的体外炎症模型.
- 用ELISA,免疫组织化学,共免疫沉,共聚焦显微镜,分子对接和SPR测试来分析MA对炎症和炎症细胞路径的影响.
主要成果:
- 在小鼠中,MA显著缓解了CDI症状,包括体重改善,结肠长度改善,细胞病理损伤减少.
- 在体内和体外,MA对IL- 1β的分泌量有所降低.
- MA抑制了炎症组合和ASC斑块的形成,分子研究显示MA和ASC之间具有强烈的结合亲和力.
结论:
- 通过抑制C. difficile毒素诱导的炎症酶激活,Madecassoside (MA) 显示出对CDI的治疗潜力.
- MA的机制涉及与ASC的结合,这表明它是新的CDI治疗策略的有希望的候选者.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:21Drugs for Treatment of Constipation-Predominant IBS
326
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
326
01:17Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383